SAT-238 Predictors Of Vaginal/Uterine Bleeding With Oral TX-001HR (Estradiol and Progesterone) Capsules Taken For Menopausal Vasomotor Symptoms

Vaginal bleeding associated with hormone therapy (HT) is the most common reason for treatment discontinuation. Cumulative amenorrhea rates (no bleeding or spotting for 13 cycles) ranging from 23% to 49% with current HT options(1-3) are relatively lower than the 56% to 73% observed in the REPLENISH t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Endocr Soc
Autori principali: Constantine, Ginger, Goldstein, Steven, Pickar, James, Graham, Shelli, Bernick, Brian, Mirkin, Sebastian
Natura: Artigo
Lingua:Inglês
Pubblicazione: Endocrine Society 2019
Soggetti:
Reproductive Endocrinology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6551826/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-238
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi